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Abstract. 
 
Presenilin 1 (PS1) is the causative gene for 
an autosomal dominant familial Alzheimer’s disease 
(AD) mapped to chromosome 14. Here we show that 
QM/Jun-interacting factor (Jif)-1, a negative regulator 
of c-Jun, is a candidate to mediate the function of PS1 
in the cell. We screened for proteins that bind to PS1 
from a human embryonic brain cDNA library using the 
two-hybrid method and isolated one clone encoding the 
QM/Jif-1 gene. The binding of QM/Jif-1 to full-length 
PS1 was conﬁrmed in vitro by pull-down assay, and in 
vivo by immunoprecipitation assays with human sam-
ples, including AD brains. Immunoelectronmicroscopic 
analysis showed that QM/Jif-1 and PS1 are colocalized 
at the endoplasmic reticulum, and the nuclear matrix in 
human brain neurons. Chloramphenicol acetyltrans-
ferase assays in F9 cells showed that PS1 suppresses 
transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos 
heterodimers, consistent with the reported function of 
QM/Jif-1. By monitoring ﬂuorescent recombinant pro-
tein and by gel mobility shift assays, PS1 was shown to 
accelerate the translocation of QM from the cytoplasm 
to the nucleus and to thereby suppress the binding of
c-Jun homodimer to 12-O-tetradecanoylphorbol-13-
acetate (TPA)-responsive element (TRE). PS1 sup-
 
pressed 
 
c-jun
 
–associated apoptosis by retinoic acid in 
F9 embryonic carcinoma cells, whereas this suppression 
of apoptosis is attenuated by mutation in PS1. Collec-
tively, the novel function of PS1 via QM/Jif-1 inﬂuences
 
 
 
c-
 
jun
 
–mediated transcription and apoptosis.
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M
 
UTATIONS
 
 in the presenilin 1 (PS1)
 
1
 
 gene have
been shown to influence the intracellular metab-
 
olism of 
 
b
 
-amyloid (A
 
b
 
) and increase the ratio
of A
 
b
 
1-42 peptides, which appears to be more fibrillogenic
than A
 
b
 
1-40 in patient plasma as well as in brains of trans-
genic mice (for reviews see Hardy, 1997; Selkoe, 1997;
Masters and Beyreuther, 1998). Furthermore, amyloid de-
posits are actually formed earlier in doubly transgenic
mice coexpressing mutant PS1 and mutant amyloid pre-
cursor protein (APP) than in age-matched mice (Borchelt
et al., 1997; Holcomb et al., 1997), consistent with human
Alzheimer’s disease (AD) pathology.
In addition to the gained function of mutant genes, PS1
is physiologically indispensable for embryonic morpho-
 
genesis. PS1
 
2
 
/
 
2
 
 mice exhibited abnormal patterning of the
axial skeleton and spinal ganglia and developed cerebral
cavitation (Shen et al., 1997; Wong et al., 1997). PS1 is a
multipass transmembrane protein homologous to SEL-12,
a 
 
Caenorhabditis elegans
 
 protein that mediates the signal-
ing from Notch/Lin-12 family cell surface receptors (Levi-
tan and Greenwald, 1995), and has been localized to endo-
plasmic reticulum (Kovacs et al., 1996), Golgi apparatus
(Kovacs et al., 1996), nuclear membrane (Li et al., 1997),
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1. 
 
Abbreviations used in this paper:
 
 A
 
b
 
, 
 
b
 
-amyloid; AD, Alzheimer’s dis-
ease; 
 
a
 
L, anti-loop antibody; 
 
a
 
N, anti–NH2-terminal antibody; AP, acti-
vated protein; APP, amyloid precursor protein; CAT, chlorampheni-
 
col acetyltransferase; EGFP, enhanced green fluorescent protein;
 
GLUT1, glucose transporter 1; GST, glutathione 
 
S
 
-transferase; Jif, Jun-
 
interacting factor; JNK, c-Jun NH
 
2
 
-terminal kinase; nt, nucleotide(s); PS1,
presenilin 1; RT, reverse transcriptase; TRE, 12-O-tetradecanoylphorbol-
13-acetate (TPA)-responsive element. 
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and plasma membrane (Dewji and Singer, 1997). PS1 is
proteolytically cleaved into two fragments (Thinakaran et al.,
1996), then presumably degraded by proteasome (Kim et al.,
1997). During development, mutant PS1 molecules appear
to function normally, because before the onset of disease,
neither morphological nor functional abnormalities are
observed in patients associated with the PS1 mutations.
Functional analyses of PS1 still remain controversial.
PS1 was shown to participate directly in the cleavage of
APP (Wolfe et al., 1999). Meanwhile, a number of mole-
cules, including calsenilin (Buxbaum et al., 1998), 
 
b
 
-cate-
nin (Zhang, Z., et al., 1998), filamin (Zhang, W., et al.,
1998), and tau (Takashima et al., 1998), were reported to
bind to PS1, some of which were assumed to affect cell
death signaling. Furthermore, although amyloid plaque
formation has been thought to be a central event in the
pathogenesis of AD, it was reported that neuronal death
enhanced by mutant PS1 transgene precedes extracellular
amyloid deposition in aged transgenic mice (Chui et al.,
1999).
Therefore, it is necessary to further characterize mole-
cules interacting with PS1 in order to understand the
mechanism underlying this complex and wide spectrum of
cellular functions for the PS1 molecule. In this study, we
found that QM/Jun-interacting factor (Jif)-1 (Dowdy et al.,
1991; Monteclaro and Vogt, 1993), a transcription factor
that interacts with c-
 
jun
 
 and inhibits its transcriptional ac-
tivation, binds to full-length PS1. We also found that QM/
Jif-1 and PS1 are colocalized in neurons of the human
brain, including those affected by PS-1–linked familial
AD, and that full-length PS1 mediates the effects of QM/
Jif-1 on c-Jun–mediated function. These results suggest
that QM/Jif-1 is another molecule mediating the function
of PS1.
 
Materials and Methods
 
Two-Hybrid cDNA Cloning
 
cDNA encoding full-length PS1 was amplified from human hippocampal
mRNA (Clontech) by reverse transcriptase PCR using primers F, 5
 
9
 
-
AAAGAATTCATGACAGAGTTACCTGCACCGT-3
 
9
 
 (sequence data
available from EMBL/GenBank/DDBJ under accession no. L42110; nu-
cleotides [nt] 249–270) and R, 5
 
9
 
-AAACTCGAGCCATGGGATT-
CTAACCGC-3
 
9 
 
(nt 1677–1660), and subcloned between EcoRI and XhoI
sites of pEG202–LexA fusion plasmid. After confirming that cotransfec-
tion of the pEGPS1 and pJG4-5 plasmids does not show nonspecific bind-
ing, 
 
z
 
5 
 
3
 
 10
 
5
 
 clones were screened from a human embryonic brain cDNA
library (provided by Dr. Roger Brent, Harvard Medical School, Boston,
MA). A second screening was performed with both SG-HWUX-gal and
SG-HWUL plates. Positive clones were subcloned into pBluescript KS
 
1
 
(Stratagene) and sequenced by using an automatic sequencer (Applied
Biosystems, Inc.).
 
Immunoprecipitation
 
100 mg of each cerebral cortex tissue was suspended in 1 ml of lysis buffer
(10 mM Tris-HCl, pH 7.8, 1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM
PMSF, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin), incubated at 4
 
8
 
C for 10
min, and disrupted by repeated aspiration through a 21-gauge needle. Cel-
lular debris was removed by centrifugation at 10,000 
 
g
 
 for 10 min. Ali-
quots of cell lysates were incubated with various antibodies for 1 h at 4
 
8
 
C,
then precipitated with protein G–agarose (Oncogene Science). Anti–NH
 
2
 
-
terminal antibody (
 
a
 
N) and anti-loop antibody (
 
a
 
L) were used finally at
1:200 dilution. Anti-QM (C-17) polyclonal antibody (Santa Cruz Biotech-
nology) was used at 1:1,000 dilution. 
 
a
 
N antibody
 
 
 
is specific for amino ac-
ids 21–80 of human PS1 (Lah et al., 1997). 
 
a
 
L
 
 
 
is a polyclonal antiserum
 
that reacts with epitopes in the hydrophilic loop domain (amino acids 263–
407) of human and mouse PS1 (Thinakaran et al., 1996). The beads were
washed extensively with Radio-Immuno-Protein Assay buffer, then sepa-
rated by 12% SDS-PAGE, blotted to Hybond-ECL membrane (Amer-
sham Pharmacia Biotech), incubated with anti-QM polyclonal antibody
(Santa Cruz Biotechnology), then detected with ECL Western blotting
analysis system (Amersham Pharmacia Biotech).
 
Pull Down Assay
 
Expression vectors of various forms of PS1 as well as glutathione 
 
S
 
-trans-
ferase (GST)-QM fusion proteins were constructed as follows. Full-length
PS1 cDNA was amplified with primers F182 (5
 
9
 
-AAACTCGAGTC-
TATACAGTTGCTCCAATGAC, nt 232–254) and R182 (5
 
9
 
-AAATC-
TAGACCATGGGATTCTAACCGCA, nt 1677–1660) from human hip-
pocampal mRNA, and subcloned between XhoI and XbaI sites of pCIneo
mammalian expression vector (Promega). The structure and sequence
were confirmed by DNA sequencing and restriction site analyses. For
pCImPS1 carrying a mutation Met
 
®
 
Leu at codon 146 associated with
early-onset familial AD, site-directed mutagenesis was performed with
Transformer Site-directed Mutagenesis kit (Clontech) according to the
commercial protocol.
For vectors expressing GST fusion proteins in 
 
Escherichia coli
 
, QM
cDNA was subcloned between BamHI and EcoRI pGEX3X (Amersham
Pharmacia Biotech) by using PCR with synthetic primers to adjust the
reading frame. Fusion proteins linked to deleted QM (see Fig. 2 c) was
constructed similarly by using PCR. PS1 protein was synthesized and ra-
diolabeled with [
 
35
 
S]methionine (NEN) by in vitro transcription and trans-
lation with TNT T7/T3–coupled reticulocyte lysate system (Promega). In-
teraction between PS1 and GST-QM proteins was performed according to
the reported method (Chen et al., 1997).
 
Immunoelectronmicroscopy
 
5 mm
 
3
 
 of tissue was obtained from the cerebral cortex of a 37-yr-old
woman 24 h after her death by loss of blood, and fixed with 4% paraform-
aldehyde. Sections for electronmicroscopic immunocytochemistry were
postfixed in 1% osmium tetroxide, stained with 2% uranyl acetate, dehy-
drated using graded alcohol and propylene oxide, and embedded in
Eponate 12 resin. 40-
 
m
 
m sections were stained by rat mAb against PS1
 
21–80
 
(Lah et al., 1997) at 1:100–500 dilution, and anti-QM polyclonal rabbit an-
tibody (Santa Cruz Biotechnology) at 1:1,000 dilution, simultaneously.
10 nm gold-conjugated anti–rat Ig and 5 nm gold-conjugated anti–rabbit
secondary antibodies were used to localize primary antibodies. Control
experiments were performed without primary antibodies. For the analyses
with diseased brains, sections of formaldehyde-fixed and paraffin-embed-
ded cortex were deparaffinized and used for the incubation with antibod-
ies. For immunohistochemistry of the mouse brain, 40-
 
m
 
m sections were
stained by anti-QM polyclonal antibody (Santa Cruz Biotechnology) then
visualized with 0.05% 3,3
 
9
 
-DAB tetrahydrochloride and 0.01% H
 
2
 
O
 
2
 
 in
50 mM Tris, pH 7.6, as described previously (Lah et al., 1997).
 
Chloramphenicol Acetyltransferase Assay
 
Transfection was performed as described previously (Okamoto et al.,
1990; Okazawa et al., 1991). 10 
 
m
 
g of reporter plasmid and 10–20 
 
m
 
g of ef-
fector plasmids were used. 10–20 
 
m
 
g pBluescript KS
 
1
 
 (Stratagene) was
added to equilibrate the total amount of plasmids for transfection. Con-
struction of effector and reporter plasmids was reported previously (An-
gel et al., 1987). Efficiency of tranfection was verified by pCH110 (Amer-
sham Pharmacia Biotech), a eukaryotic vector containing the simian virus
early promoter and 
 
E. coli
 
–
 
b
 
-galactosidase (LacZ) structural gene. Each
experiment was repeated at least four times and variation of transfection
efficiency was 
 
,
 
20%.
 
Enhanced Green Fluorescent Protein Fusion Protein 
Expression Vectors
 
Expression vectors of fluorescent protein–QM fusion proteins were con-
structed by inserting various forms of QM cDNAs into pEGFPN1 (Clon-
tech). Full-length QM cDNA was amplified by RT-PCR from human
amygdala mRNA with the primers QMF (AACGAATTCCCATGGGC-
CGCCGCCCCGCCCGTT) and QMR (AATGGATCCGTGAGTGCA-
GGGCCCGCCA), and subcloned between EcoRI and BamHI sites of
pEGFPN1. 
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c-Jun NH
 
2
 
-terminal Kinase Activity Assay
 
The effect of PS1 on c-Jun NH
 
2
 
-terminal kinase (JNK) activities was ana-
lyzed by transfecting 6 
 
m
 
g of T7-tagged JNK1 with 10 
 
m
 
g of pCIPS1 or
pBS-KS as control into F9 cells. JNK1 protein was recovered by immuno-
precipitation with mouse mAb against T7 epitope (Invitrogen). After the
Sepharose resin was washed five times with lysis buffer containing 20 mM
Tris-HCl, pH 8.0, 2 mM EDTA, 50 mM 
 
b
 
-glycerophosphate, 0.1 mM
Na
 
3
 
VO
 
4
 
, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 10% glycerol,
1 mM PMSF, 10 
 
m
 
g/ml leupeptin, and 10 
 
m
 
g/ml aprotinin, the proteins
were recovered with SDS sample buffer and analyzed by Western blotting
with anti–T7-Tag antibodies.
 
Retinoic Acid–induced Apoptosis
 
To make stable cells expressing antisense c-
 
jun
 
, pCIneo (Promega) con-
taining the full-length c-
 
jun
 
 cDNA at the reverse orientation was con-
structed and transfected into F9 cells. They were selected in 
 
a
 
-medium
(Sigma Chemical Co.) with 300 
 
m
 
g/ml G418 for 2 wk. Stable cells express-
ing normal or mutant PS1 were similarly made by transfecting pCIPS1 and
pCImPS1. 1 
 
3
 
 10
 
5
 
 F9 or stable cells were cultured in 
 
a
 
-medium: 10% FBS
with 1 
 
m
 
M all-trans retinoic acid (Sigma Chemical Co.) for 48 h. All the
cells were collected and their genomic DNA were extracted and separated
on 3% Nusieve-agarose gel (FMC BioProducts).
For analysis of the effect of deletion constructs of QM on apoptosis, 1 
 
3
 
10
 
5
 
 F9PS1 cells were transiently transfected with 20 
 
m
 
g of each expression
vector described below using SuperFect (Qiagen) in a 10-cm tissue culture
dish. 24 h after transfection, cells were treated with 1 
 
m
 
M all-trans retinoic
acid (Sigma) for an additional 48 h. All the cells were collected and the
percentage of cell death was estimated by trypan blue dye exclusion.
 
Deletion Constructs of QM/Jif-1
 
QM/Jif-1 cDNA fragments were amplified with RT-PCR from human
hippocampal mRNA (Stratagene). The primers used were F1 (AAACTC-
GAGCCTGGTGTCGCCATG; sequence data available from EMBL/
GenBank/DDBJ under accesion no. M64241; nt 30–44), R1 (AAA-
GAATTCAATTCGGGCAGCCTCCA, nt 251–235), F2 (AAAGAAT-
TCCGCATCAACAAGATGT, nt 333–348), R2 (AAATCTAGAAGC-
CCTCATGAGTGCA, nt 691–676), and R3 (AAATCTAGAACATC-
TTGTTGATGCG, nt 348–333). Different portions of QM cDNA were
amplified with F1 and R3 for 
 
D
 
1 or with F1 and R1 for 
 
D
 
2, digested with
XhoI and XbaI or with XhoI and EcoRI, and subcloned into correspond-
 
ing sites of pCIneo vector (Promega), respectively. For 
 
D
 
3, two cDNA
fragments amplified with F1/R1 or F2/R2 were digested with XhoI/EcoRI
or with EcoRI/XbaI, respectively, then subcloned between XhoI and
XbaI sites of pCIneo.
 
Results
 
Identification of QM/Jif-1, a Negative Regulator of
c-Jun, as a Binding Protein to PS1
 
We have investigated the function of PS1 by isolating the
molecules that interact with PS1. We screened a human
embryonic brain library using the yeast two-hybrid system.
After double second screens using leucine-deficient plates
and X-gal plates, we finally judged six clones showing
strong interaction to be positive. In our experience with
the two-hybrid system, this number of positive clones was
small compared with other baits. Among them, we found a
clone identical to QM/Jif-1. This molecule was isolated
originally as a putative Wilms’s tumor suppressor gene
(Dowdy et al., 1991), then described as a transcription fac-
tor that interacts with c-Jun and inhibits its transcriptional
activation (Monteclaro and Vogt, 1993). Recently, it was
shown to be identical to a ribosomal protein, L10 (Chan
et al., 1996), which was therefore suggested to be a riboso-
mal protein possessing multiple extraribosomal functions
(Wool, 1996).
This clone (PS309-4) lacked an NH
 
2
 
-terminal portion of
43 amino acids and encoded a variant Ser202Asn (Fig. 1
a). QM/Jif-1 does not possess a leucine zipper but might
compose a C2H2-type zinc finger (Fig. 1 a). Retransforma-
tion of EGY48 yeast cells by pEGPS1 and pJGPS309-4
plasmids showed high 
 
b
 
-galactosidase activities in inde-
pendent yeast colonies (Fig. 1 b).
To determine the binding domain of PS1 molecule to
QM/Jif-1, we performed deletion analysis of PS1 by two-
Figure 1. (a) Protein se-
quence of QM/PS309-4. Ar-
row indicates NH2-terminal
end of the PS309-4 clone.
Amino acid substitution in
PS309-4 (Ser202Asn) is indi-
cated with a bold letter. (b)
Two-hybrid interaction be-
tween PS309-4 and PS1.
pJGPS309-4 was retransfected
into EGY48 yeast cells that
had been transformed by
pEGPS1 bait plasmid and
pSH18-34 reporter plasmid. Two independent colonies were picked up from SD-HWU plate and tested on SG-HWUL and SG-HWU-
Xgal plates. Negative (pEGPS1/pJG4-5) and positive (pEGShc/pJGShc) controls were equally tested. (c) Two-hybrid analysis on inter-
action between QM and various portions of the PS1 protein. Partial cDNAs corresponding to the number of amino acids of the dele-
tion plasmids were amplified by PCR with synthetic primers and subcloned into pEG. EGY48 yeast cells were cotransfected with these
pEG vectors, pJGPS309-4 and pSH18-34, and then incubated for 2 d on selection plates. Quantitative analysis of b-galactosidase activ-
ity was performed according to the standard protocol (Guarente, 1983). 
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hybrid assay. cDNAs corresponding to various regions of
the PS1 molecule were subcloned into the pEG vector and
cotransfected with pJG309-4 into yeast cells. Interestingly,
any partial sequence of PS1 did not bind strongly to QM/
Jif-1. Instead, full-length PS1 showed a strong interaction
with QM/Jif-1 (Fig. 1 c). This finding corresponds well to
the results of Western blot analysis using human brains de-
scribed below.
 
In Vivo Interaction between QM/Jif-1 and PS1
 
To verify the interaction between QM and PS1 in vivo, we
performed immunoprecipitation assay with human brains,
including those of familial and nonfamilial AD patients.
Approximately 50 kD full-length PS1 was detected in the
precipitates by 
 
a
 
N and by 
 
a
 
L from normal, disease control
(amyotrophic lateral sclerosis), nonfamilial AD, and PS1-
linked AD brains (Fig. 2 a), whereas we could not observe
clear bands corresponding to the cleaved PS1 fragments.
This result in human brain, together with the results from
two-hybrid deletion analyses (Fig. 1 c), suggest that multi-
ple regions in the full-length structure of PS1 are necessary
for tight interaction with QM/Jif-1. This idea might have
some relationship to the recent finding that NH
 
2
 
- and
COOH-terminal PS1 fragments reassociate and form a
stable complex (Capell et al., 1998; Thinakaran et al.,
1998).
Interestingly, the band was visible but very weak in
lanes 6 and 7 loaded with samples from PS1-linked AD pa-
tients (Fig. 2 a). Compared with the PS1 bands in Western
blot analysis using the same brain samples (Fig. 2 b), it is
not due to difference of the PS1 protein amounts among
brain samples. Instead, it could be due to the difference of
residual neurons where QM and PS1 may interact, among
samples, or due to the difference in affinity of QM to nor-
mal and mutant PS1. In the reverse immunoprecipitation
assay, we detected QM in precipitates by 
 
a
 
N as well as by
 
a
 
L (Fig. 2 c), reconfirming the interaction between PS1
and QM/Jif1 in vivo. We performed immunoprecipitation
with nonimmune sera and with several nonspecific anti-
sera using the same brain samples, but did not find QM or
PS1 in the precipitates (data not shown).
 
PS1 and QM/Jif-1 Colocalize in Cortical Neurons
 
To observe the interaction between QM and PS1 in the
brain morphologically, we performed immunohistochemi-
cal analyses. As QM expression has not been reported pre-
viously, we confirmed that the QM message is widely ex-
pressed in the brain by Northern blot analysis (Fig. 3). At
the light microscopic level, anti-QM polyclonal antibody
stained the cytoplasm of neurons in the mouse cerebral
cortex (Fig. 4 a). To further characterize subcellular local-
ization of the QM protein, we observed the mouse brain
sample with electronmicroscopy and found that regions
very close to tubular membrane structures, which pos-
sessed features of smooth endoplasmic reticulum, were
predominantly stained (Fig. 4, b and c). This subcellular
localization of QM was exactly like that of PS1 reported to
date (Lah et al., 1997).
Next, we asked whether the QM and PS1 proteins are
colocalized in the human brain neurons. Immunohis-
tochemical analysis was performed with secondary anti-
bodies conjugated to different sizes of gold particles and
with the brain of a 37-yr-old woman who died due to loss
of blood. We observed that the 5-nm grain of PS1 and 10-
nm grain of QM were located very close to each other at
the edge of smooth membrane structures in the cytoplasm
of cortical neurons (Fig. 4 d). Most of those structures
seemed to be smooth endoplasmic reticulum, whereas
some of them possessed the features of Golgi apparatus
(data not shown). Fewer grains were observed also in the
nucleus (Fig. 4 e). Although the immunoreactivity was fur-
ther reduced in the formaldehyde-fixed and paraffin-embed-
ded tissues of nonfamilial or PS1-linked AD brains, we re-
Figure 2. (a) The full-length PS1
was coprecipitated with QM by
anti-QM antibody from cerebral
cortex tissues of normal (samples 1
and 2), disease control (amytrophic
lateral sclerosis) (sample 3), nonfa-
milial AD (samples 4 and 5), or
PS1-linked AD brains (samples 6
and 7). Sample 6 was from a patient
with a Met146Leu mutation, and sample 7 was from a patient
with an Ala246Glu mutation. An approximately 50-kD band of
the full-length PS1 was detected by aN and aL. Immunoprecipi-
tate from a normal brain (sample 1) by nonspecific serum (NS)
was similarly detected as a negative control. The same filters
were reprobed by anti-QM antibody (lower panels) to confirm
that equal amounts of the protein samples were loaded on the
gels. (b) Western blot analysis of the same human brain samples
with aN and aL. (c) QM was coprecipitated with PS1 by aN or
aL antibodies from the cerebral cortex of normal human brain.
Nonspecific serum (NS) was used for immunoprecipitation as a
negative control. 
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peatedly found that these two grains were colocalized at
membrane structure in the cytoplasm (Fig. 4, f–i).
PS1 Suppresses the Action of c-jun Homodimer
Next, we investigated the biological significance of the in-
teraction between QM/Jif-1 and PS1. Jif-1 was isolated as
a protein binding to c-Jun from a cDNA library screened
with biotinylated c-Jun (Monteclaro and Vogt, 1993).
Work by Monteclaro and Vogt on the function of Jif-1 has
shown that GST–QM/Jif-1 fusion proteins do not bind
to 12-O-tetradecanoylphorbol-13-acetate (TPA)-responsive
element (TRE) in gel mobility shift assays, but prevent the
binding of a c-Jun homodimer to the TRE (Monteclaro
and Vogt, 1993). Moreover, the c-Jun/c-Fos heterodimer
can override this inhibition by Jif-1. Through this binding
inhibition, Jif-1 inhibits gene transactivation by c-Jun.
QM/Jif-1 is extremely conserved during evolution from
yeast to mammal (Farmer et al., 1994), suggesting that this
factor is essential for basic cellular functions. From these
observations, we supposed that expression of PS1 might
affect the function of c-Jun through interaction with QM.
To test this hypothesis, we performed cotransfection
chloramphenicol acetyltransferase (CAT) assays with
c-jun or c-fos expression vectors as the first effector plasmid,
normal or mutant PS1 expression vectors as the second ef-
fector plasmid (Fig. 5 a), and human collagenase (2517/
242) TKCAT vector containing TRE as reporter plasmid.
We used F9 embryonic carcinoma cells in the assays be-
cause they possess almost no activated protein (AP)-1 ac-
tivity (Angel et al., 1988), but express enough of the QM
protein (data not shown). It was difficult to predict what
kind of results would emerge with the addition of the PS1
expression vector, because the binding might keep QM in
the endoplasmic reticulum where PS1 is most abundant
(Kovacs et al., 1996), or it might assist the transport of QM
to the nucleus where PS1 immunoreactivity is also de-
tected (Li et al., 1997). It could be that cotransfection
might not affect CAT activities due to a nonfunctional
binding between the two molecules.
Among these possibilities, we obtained the simplest and
clearest outcome. c-jun or c-jun/c-fos transactivated the
CAT gene expression (Fig. 5 b) as expected. The transacti-
vation by c-Jun homodimer was suppressed by normal PS1
as well as mutant PS1, whereas the transactivation by
c-Jun/c-Fos heterodimer was not affected by adding PS1
expression vectors (Fig. 5, a and b). This suppressive effect
was considered to be specific, because overexpression of a
multipass transmembrane protein, glucose transporter 1
(GLUT1), which is known to move from the endoplasmic
reticulum to the Golgi apparatus, did not suppress CAT
activity (Fig. 5 b). The weak transactivation by c-Fos,
which might have been induced with a weak endogenous
c-Jun activity, was not influenced by either normal or mu-
tant PS1. These observations corresponded very well with
the interacting behavior of QM to AP-1 molecules re-
ported previously (Monteclaro and Vogt, 1993). The sup-
pression by mutant PS1 seemed weaker than that by nor-
mal PS1 (Fig. 5 b).
To examine whether the effect of PS1 is mediated by
TRE, we changed the reporter plasmid to those that con-
tained only TRE (Fig. 5 a). As expected, PS1 reproduced
Figure 3. Northern blot analyses of the QM ex-
pression in various organs and various regions of
the brain. PS309-4 cDNA was used as the probe.
The final wash was 0.13 SSC/0.1% SDS at 608C
for 60 min. nucl, nucleus.The Journal of Cell Biology, Volume 147, 1999 126
suppression of the c-Jun–mediated transactivation in col-
lagenase 13 TRE CAT and metallothionein IIa 13 TRE
CAT (Fig. 5 c). These results supported our hypothesis
that PS1 affects gene regulation by c-jun through TRE. In-
terestingly, by using 13 TRE CAT plasmids, we observed
more clearly that the suppression of c-Jun–induced trans-
activation was weaker in mutant PS1 than in normal PS1
(Fig. 5 c).
PS1 Represses Transactivation by junD but Not
by junB
Second, we tested whether PS1 affects transcriptional reg-
ulation by the other c-jun family members forming an
AP-1 complex. Expression of junB and junD enhanced
transcription from collagenase 13 TRE CAT reporter
plasmid (Fig. 5 d). Transactivation by junD was clearly
suppressed by expression of normal and mutant PS1,
whereas transactivation by junB was not affected (Fig. 5
d). In this case, suppression of junD-mediated transactiva-
tion by normal PS1 was not remarkably different from that
by mutant PS1 (Fig. 5 d), in contrast to our observations
with c-jun–mediated transactivation (Fig. 5, b and c). In
the CAT assays described above, we confirmed that ex-
pression of the c-Jun protein was not influenced by
cotransfecting PS1, and that expression of normal and mu-
tant PS1 proteins was equivalent (Fig. 5 e). We summa-
rized results from all the CAT assays described above with
a histogram showing mean fold transactivations (Fig. 5 f).
PS1 Promotes Translocation of QM/Jif-1 to the Nucleus
From the data described above, we hypothesized that PS1
somehow promotes translocation of the QM protein from
Figure 4. (a) Light micro-
scopic immunohistochemis-
try of the mouse cerebral cor-
tex. Cytoplasm of the cortical
neurons are stained by anti-
QM antibody. Bar, 5 mm. (b)
Electron microscopic immu-
nohistochemistry with DAB
showing a single neuron in
the mouse cerebral cortex.
The cytoplasm is stained in a
granular manner. Bar, 1 mm.
(c) High power magnification
of a neuron in the mouse ce-
rebral cortex. DAB staining
is located mainly at smooth
tubular membrane structures
(arrows). Bar, 100 nm. (d)
Electron microscopic immu-
nohistochemistry of a human
cortical neuron with gold-
conjugated secondary anti-
bodies. QM (5-nm gold
grains) and PS1 (10-nm gold
grains) are located predomi-
nantly around smooth mem-
brane structures. Bar, 100
nm. (e) Grains of PS1 and
QM in the nucleus (nucl) of a
human cortical neuron are
fewer than those in the cyto-
plasm, but sometimes colo-
calized. Bar, 100 nm. (f–i) 5-
and 10-nm grains exist close
to each other (arrow heads)
in normal human brain (f),
nonfamilial AD human brain
(g), PS1-linked AD human
brain (h), and in amyotrophic
lateral sclerosis human brain
(i). Bar, 100 nm (f–i).Imafuku et al. PS1 Suppresses c-Jun 127
Figure 5. (a) Constructions of PS1 expression vectors and 13 TRE CAT plasmids. PS1 cDNAs were subcloned into pCIneo directed by
the cytomegalovirus immediate early enhancer/promoter. For 13 TRE CAT plasmids, synthetic oligonucleotides were inserted into
tkCAT. (b) CAT assay showing the effect of normal or mutant (Met146Leu) PS1 on c-jun-, c-fos-, or c-jun/c-fos–mediated transactiva-
tion. Expression of normal as well as mutant PS1 repressed transactivation of the collagenase gene enhancer/promoter by c-jun but not
by c-fos or c-jun/c-fos. As control, effect of GLUT1 on c-jun–induced transactivation was examined. pBluescript KS1 was added to
equilibrate total amounts of plasmids. (c) CAT assay using various 13 TRE CAT reporter plasmids. Cotransfection of PS1 clearly sup-
pressed transactivation by c-jun on 13 TRE vectors. (d) CAT assay using junB and junD expression vectors. PS1 expression suppressed
junD-induced transactivation but not junB-induced transactivation. (e) Protein expression of c-Jun and of normal or mutant PS1 in
transfected cells used for CAT assays. Proteins were prepared from the cells used for CAT assays, separated by SDS-PAGE, and de-
tected by anti–c-Jun antibody (aJun) or by anti–PS1-loop antibody (aPS1L). The bands corresponding to c-Jun, full-length PS1, and
COOH-terminal fragment of PS1 were indicated by arrowheads. Lanes 1–4 correspond to lanes 1–4 in b. (f) Histogram showing the
mean fold transactivation of multiple assays.The Journal of Cell Biology, Volume 147, 1999 128
the cytoplasm to the nucleus, inhibits the binding of c-Jun
homodimer to TRE, and thereby suppresses transactiva-
tion by c-jun. We used a fluorescent protein (enhanced
green fluorescent protein [EGFP]) fusion reporter plas-
mid to observe how intracellular transport of the QM pro-
tein is modulated by PS1, and observed that translocation
of the fusion protein to the nucleus is actually accelerated
by cotransfecting PS1 (Fig. 6 a). On the other hand, coex-
pression of mutant (Met146Leu) PS1 did not remarkably
promote the nuclear translocation.
It is interesting to note that the effects of PS1 on tran-
scription and on protein transport were remarkable al-
though the expression level of PS1 was not as high as that
of PS1 (Fig. 5 e), or as the endogenous expression level of
QM/Jif-1 (data not shown). Considered with the function
of PS1 assisting the nuclear transport of QM, transfected
PS1 molecule might be recycled efficiently in cells, leading
to the remarkable effect on c-Jun function via QM protein
translocated to and accumulated in the nucleus.
Next, we performed gel mobility shift assays by using
nuclear extracts prepared from F9 cells expressing AP-1
transcription factors with or without PS1. We found that
PS1 suppresses the binding of c-Jun homodimer to TRE
and very weakly suppresses that of JunD homodimer but
not that of c-Jun/c-Fos heterodimer or JunB homodimer
(Fig. 6 b). Furthermore, normal PS1 suppressed the bind-
ing to TRE more efficiently than mutant PS1 (Fig. 6 b).
These findings are consistent with the results in CAT assay
(Fig. 5, a–f) and support the idea that the nuclear translo-
cation of QM/Jif-1 is promoted by normal PS1 thereby in-
hibiting the binding of c-Jun homodimer to TRE.
We tested another possibility that PS1 inhibits JNK and
thereby suppresses transactivation by c-jun (for review see
Minden and Karin, 1997). T7-Tag-JNK1 expression vector
was cotransfected with PS1, immunoprecipitated, and the
JNK activity was tested with c-Jun produced in bacteria as
a substrate. In this assay, we observed no change of JNK
activity (data not shown). This finding indicates that PS1
represses the function of c-jun predominantly through the
transport of QM/Jif-1, but not through c-Jun phosphoryla-
tion by JNK, although further analyses are necessary to
determine whether or not JNK is partially involved in the
suppression by PS1.
Mutation Attenuates Inhibition of c-jun–Mediated 
Apoptosis by PS1
c-jun had been characterized as a protooncogene promot-
ing cellular proliferation, whereas recent data indicate that
c-jun is involved in some types of apoptosis. Expression of
c-jun dominant negative mutants protects sympathetic
neurons against cell death induced by NGF withdrawal,
Figure 6. (a) Translocation of EGFP-QM fusion protein to the nucleus was promoted by cotransfecting normal PS1. When pEGFQM
was transfected alone into F9 cells, it was distributed predominantly in the cytoplasm. By coexpressing normal PS1, distribution of the
EGFP-QM fusion protein was shifted to the nucleus. This nuclear translocation was not obvious when mutant (Met146Leu) PS1 was co-
expressed. Expression of normal and mutant PS1 proteins was equivalent in Western blot analysis performed similarly to Fig. 5 e. Per-
centage of nuclear translocation was calculated by (number of cells with stronger fluorescence in the nucleus)/(total number of fluores-
cence-positive cells) 3 100. About 100 fluorescence-positive cells were observed in each transfection. (b) Gel mobility shift assay
showing the effect of normal or mutant PS1 on the DNA-protein binding of various AP-1 complexes. F9 cells were transfected by c-jun,
c-jun/c-fos, junD, or junB expression vectors with pBluescript as control, normal PS1 (PS1), or mutant PS1 (mPS1). 10 mg of each plas-
mid was transfected by calcium phosphate method and nuclear extract was prepared 36 h after transfection. Oligonucleotide corre-
sponding to metallothionein IIa TRE was radiolabeled with Klenow enzyme and used as the probe. C, DNA–protein complex. F, free
probe. Cotransfection of normal PS1 remarkably suppressed the binding of c-Jun homodimer, whereas mutant PS1 suppressed weakly.
The DNA–protein complex of the c-Jun/c-Fos heterodimer and JunB homodimer was not remarkably affected. The complex of the
JunD homodimer was inhibited weakly.Imafuku et al. PS1 Suppresses c-Jun 129
and the overexpression of c-jun itself triggers apoptosis in
sympathetic neurons (Ham et al., 1995). Transfection of a
recombinant fusion protein chimera of c-Jun and hormone
binding domain of estrogen receptor induces apoptosis in
NIH 3T3 cells with b-estradiol added to the culture me-
dium (Bossy-Wetzel et al., 1997). Furthermore, induction
of  c-fos is noted as an early event of programmed cell
death (Smeyne et al., 1993), and c-fos is implicated in light-
induced retinal degeneration (Hafezi et al., 1997). Inter-
estingly, the time course of the protein expression in neu-
ronal apoptosis induced by withdrawal of trophic factor
was different. c-jun is upregulated at first and c-fos follows
it; expression of junD does not change (Ham et al., 1995).
These findings indicated that AP-1 plays important roles
in cell death, although each member of the AP-1 complex
might play a different role.
Considering these previous data, we examined whether
PS1 affects c-jun–mediated apoptosis. We used F9 cells for
this analysis, since retinoic acid treatment induces apopto-
sis (Atencia et al., 1994) and upregulation of the c-jun
expression (Yamaguchi-Iwai et al., 1990). Suppression
of c-jun by the antisense transcript expression reduced the
retinoic acid–induced apoptosis (Fig. 7 a), indicating that
c-jun mediates this type of cell death. Thus, we made stable
transformants expressing .10 times the amount of PS1
protein than parental F9 cells (Fig. 7 b), and observed the
effect of PS1 on retinoic acid–induced apoptosis. Apoptotic
cells were detected by nick end labeling assay with terminal
transferase (Fig. 7 c) and by trypan blue dye exclusion as-
say (Fig. 7 d) then analyzed statistically (Fig. 7 d). Normal
PS1 significantly suppressed the percentage of apoptotic
cells, whereas mutant PS1 suppressed it rather weakly.
These results were consistently observed in the stable cell
lines with high expression (n 5 3). In addition, we con-
firmed these results by DNA fragmentation in cellular nu-
clei (Fig. 7 e). The weak antiapoptotic effect of mutant PS1
corresponds well to its weak suppressive effect on c-jun–
induced transactivation in CAT assays (Fig. 5, b, c, and f).
The Putative Zinc Finger Domain Is Essential for 
Interaction with PS1
At the end of this study, we investigated the role of the pu-
tative zinc finger domain (zif) of QM/Jif-1 in interaction
with PS1, in transcriptional regulation, and in apoptosis.
First, we made various deletion constructs of QM/Jif-1
(Fig. 8 a) and tested their binding to PS1 by pull-down as-
say. Normal or mutant (Met146Leu) PS1 radiolabeled
with [35S]methionine by in vitro transcription/translation
were interacted with GST fusion proteins of QM in vitro
and pulled down by glutathione Sepharose 4B. Full-length
QM interacted with normal PS1, whereas deletion con-
structs lacking zif did not bind to PS1 (Fig. 8 b), indicating
that this region is essential for interaction. Mutant PS1
binds to the GST-QM fusion proteins similarly. However,
the ratio between the input and the pulled-down amounts
was lower in mutant PS1 (60%) than in normal PS1 (95%).
Next, we tested whether deletion of zif affects transcrip-
tional regulation. As QM/Jif-1 is abundantly expressed in
all the cell lines, we designed a dominant negative experi-
ment. We selected F9PS1 cells in which transfected QM is
translocated to the nucleus. Eukaryotic expression vectors
containing the deletion constructs of QM were cotrans-
fected with c-jun, and QM expression vectors into F9PS1
cells. Transfection of full-length QM suppressed c-jun–
induced transactivation (Fig. 8 c, lanes 2 and 3). D1 antag-
onized this suppression by QM. The CAT activities in
cotransfection of D1 (Fig. 8 c, lanes 4 and 5) was higher
than those in c-jun–induced transactivation (Fig. 8 c, lane
2), suggesting that D1 antagonized endogenous QM in ad-
dition to transfected QM. This dominant negative effect
was not observed in the other constructs without zif that
cannot interact with PS1 (Fig. 8 c, lanes 6–9). Therefore,
D1 probably inhibits binding of QM to PS1 in a competi-
tive manner and represses the function of QM, since D1
transported to the nucleus does not have a suppressive ef-
fect on c-Jun. Consistently, translocation to the nucleus of
the GFP fusion protein was observed in D1 but not in the
other deletion constructs lacking zif (Fig. 8 d). Without
transfecting c-jun expression vector, transactivation by D1
itself was not observed in F9PS1 cells, which do not ex-
press c-jun (data not shown).
Finally, we tested the role of zif in the c-jun–associated
apoptosis. F9PS1 cells were transfected with the vectors
expressing deleted QM/Jif-1. Transfection of D1 increased
the percentage of cell death induced by retinoic acid treat-
ment, whereas the other constructs did not affect the apop-
tosis (Fig. 8 e). This result again showed the dominant
negative effect of D1 on apoptosis. Collectively, it was con-
cluded that zif is essential for the interaction of QM with
PS1 and for the effects of QM on c-Jun derived from the
interaction.
Discussion
This study showed that PS1 binds to a negative cofactor of
c-Jun, QM/Jif-1, and that PS1 regulates the functions of
c-jun in transcription and cell death. Promotion of the nu-
clear translocation of QM/Jif-1 by PS1 seems to be the un-
derlying mechanism that connects the first and second
conclusions. A specific point in our results is that QM/Jif-1
binds to a full-length PS1. It was reported that most PS1
molecules are cleaved into two fragments which reassoci-
ate to form a heterodimer (Thinakaran et al., 1996, 1998).
However, Western blot analysis in this study (Fig. 2, a and
b) and in the previous reports (Lah et al., 1997) shows that
full-length PS1 also exists in the brain in vivo, although the
function of this form has been unclear. Our findings sug-
gest that the full-length form also possesses a functional
role related to cell viability.
So far, more than five molecules, including APP (War-
agai et al., 1997; Xia et al., 1997), calsenilin (Buxbaum et
al., 1998), b-catenin (Zhang, Z., et al., 1998), filamin (Zhang,
W., et al., 1998), and tau (Takashima et al., 1998), were
isolated as binding proteins to PS1. The reason why many
proteins bind to PS1 is not known. However, it might be
explained by supposing that PS1 functions as a kind of in-
tracellular transporter with a relatively low specificity. The
multipass transmembrane structure of PS1, especially of
the full-length form, does not contradict this hypothesis,
and this kind of activity was actually shown in the case of
amyloid protein transport (Naruse et al., 1998). Our ob-
servation on the nuclear translocation of QM/Jif-1 is also
compatible with this idea.The Journal of Cell Biology, Volume 147, 1999 130
Activation of c-jun, especially that mediated by JNK,
has been suggested to participate in various types of cell
death, including TNF- or Fas-induced apoptosis (Verheij
et al., 1996). Numerous reports keep emerging on this
apoptotic cascade. JNK was reported to enhance apopto-
sis induced by a breast cancer susceptibility gene, BRCA1,
through activation of GADD45 (Harkin et al., 1999). The
JNK-dependent apoptotic pathway has been implicated in
the morphogenesis of Drosophila wing (Adachi-Yamada
et al., 1999). Furthermore, kainic acid–induced apoptosis
in the hippocampus was prevented in the mice lacking the
Jnk3 gene (Yang et al., 1997), indicating that JNK3 is es-
sential for this type of apoptosis. The role of JNK in kainic
acid–induced apoptosis was reconfirmed in the knock-in
Figure 7. (a) Retinoic acid–induced apoptosis was suppressed in stable cells expressing antisense c-jun. SDS-PAGE and Western blot
analysis show that expression of the c-Jun protein was induced by retinoic acid treatment in F9 cells but not in the stable cells expressing
antisense c-jun. Genomic DNA analysis of these cells shows that the DNA ladder formation corresponding to apoptosis was suppressed
in the antisense stable cells. Similar results were obtained in the other stable cell lines (n 5 3). (b) Western blot analysis with anti-PS1
loop antibody showing PS1 protein expression level in stable cells. F9PS1, a stable cell line expressing normal PS1; F9mPS1, a stable cell
line expressing mutant (Met146Leu) PS1; FL, full-length PS1; CTF, COOH-terminal fragment of PS1. (c) Nick end labeling assay show-
ing that retinoic acid–induced apoptosis was reduced remarkably in F9PS1 but mildly in F9mPS1. Fluorescent labeling of apoptotic nu-
clei was performed with Apoptosis Detection System (Promega) according to the commercial protocol. (d) Effects of PS1 or mPS1 on
retinoic acid–induced apoptosis were detected by nick end labeling assay (white bars) and by trypan blue dye exclusion analysis (shaded
bars). Three independent stable cell lines were analyzed in each overexpression. Percentage of apoptosis in eight visual fields (mean 6
SD) was significantly decreased (ANOVA, P , 0.01) in F9PS1 (cell lines 1–3) and F9mPS1 (cell lines 1 and 2) compared with F9. (e)
Genomic DNA analysis of F9 cells and stable cells expressing normal or mutant PS1 in retinoic acid–induced apoptosis. Cells were cul-
tured in the presence of 0.1 mM all-trans retinoic acid for 48 h. Both floating and adhering cells were collected together for DNA prepa-
ration. MM, molecular weight marker IV (Boehringer Mannheim).Imafuku et al. PS1 Suppresses c-Jun 131
mice carrying mutations at JNK-phosphorylation sites of
the c-jun gene (Behrens et al., 1999). In the AD brain, the
increase of c-Jun immunoreactivity was observed and
strongly correlated with pathological changes (Anderson
et al., 1996). Mutations in PS1 might influence such cas-
cades at the final step of c-Jun and thereby affect apopto-
sis. Since our results showed that the inhibitory effect of
mutant PS1 on c-jun–mediated apoptosis was weaker than
that of normal PS1, mutation in PS1 could be a promoting
factor in c-jun–mediated apoptosis.
However, there remain debates on the role of c-jun and
JNK in the in vivo apoptosis. Although double gene dis-
ruption of Jnk1 and Jnk2 leads to severe dysregulation of
apoptosis during development at specific regions in the
brain, Jnk3 does not affect this apoptosis (Kuan et al.,
1999). c-jun was reported to be dispensable in develop-
mental cell death and axogenesis of the retina (Herzog et al.,
1999). These discrepancies might suggest that the c-Jun/
JNK cascade plays different roles in the developmental
neuronal death and in the death of the mature neuron.
Therefore, our results on the cascade from PS1 to c-Jun
should be applied carefully to different types of cell death.
The functions of normal and mutant PS1 in cell death
reported so far are still difficult to combine (for review see
Barinaga, 1998). Normal PS1 had been reported to pro-
mote cell death basically via affecting the Ab metabolism.
Meanwhile, accumulating data from independent labora-
tories indicated that PS1 also modifies various cell death
cascades. It suppresses apoptosis associated with p53 and
p21WAF1 activation (Roperch et al., 1998) and promotes
the antiapoptotic function of b-catenin (Zhang, Z., et al.,
1998). In these cases, normal PS1 suppresses cell death,
whereas mutations in PS1 abort this function.
Suppression of c-Jun homodimer by PS1 might lead to a
different outcome in signaling pathways other than the
c-jun–mediated apoptosis examined in this study. For ex-
ample, neurotrophins bind to tyrosine kinase–type mem-
brane receptors and activate c-Jun through the mitogen-
activated protein (MAP) kinase pathway. Many other
trophic factors, including fibroblast (FGF), epidermal
(EGF), platelet-derived (PDGF), and hepatocyte growth
factors (HGF), induce similar signaling cascades and pro-
mote cell survival. In such a condition where the activation
of c-Jun mainly contributes to survival, PS1 might promote
apoptosis. Like neurotrophins which transduce survival
and death signalings via the high affinity and low affinity
receptors, respectively (for review see Dechant and Barde,
1997), PS1 might transduce both types of signalings via dif-
ferent molecules binding to PS1.
In other words, our results might have proposed another
type of explanation for why PS1 induces diverse effects on
the cell fate. The PS1/QM/c-Jun cascade leads to the oppo-
Figure 8. (a) Deletion construct
of QM/Jif-1 subcloned into a
GST fusion protein expression
vector or into a eukaryotic ex-
pression vector. (b) GST fusion
proteins lacking the putative zinc
finger domain (zif) did not bind
to the full-length PS1 in pull-
down assay. IP, input. (c) Dele-
tion of zif affects transcriptional
regulation. Cotransfection of
full-length QM into F9PS1 cells
suppressed c-jun–induced trans-
activation, whereas D1 enhanced
c-jun–induced transactivation.
This effect was not found in the
other constructs lacking zif. 10 or
20 mg of D1–3 was cotransfected
with 5 mg of c-jun expression vec-
tor, QM expression vector, and/
or collagenase 13 TRE CAT
into 1 3 106 F9PS1 cells. Total
amount of the transfected plas-
mids was controlled with pBlue-
script KS1. (d) QM-GFP fusion
proteins containing the deletion
constructs of QM were expressed
in F9PS1 cells, and their subcellu-
lar localization was analyzed. 1 or
2 (D2) cells were shown in each
case. QM-GFP and D1-GFP were
localized predominantly in the
nucleus in F9PS1 cells. (e) F9PS1
cells were transfected with the vectors expressing full-length or deleted QM. Transfection of D1 increased apoptoic cells in the treat-
ment with retinoic acid, whereas the other constructs did not affect the c-jun–associated apoptosis. Statistical analysis confirmed in-
crease of the percentage apoptosis in transfection of D1 (ANOVA, P , 0.01) from the value in transfection of QM.The Journal of Cell Biology, Volume 147, 1999 132
site outcome, survival or death, depending on the final ef-
fect of c-Jun, which is influenced by cellular conditions. Al-
though it is not yet known which factors define the attitude
of c-Jun in cells, other types of signaling cascades induced
by PS1, including calcium release from endoplasmic reticu-
lum (Guo et al., 1996) and G protein signaling (for review
see Nishimoto, 1998), might cross-talk and change the re-
sponding manner of cells to the c-Jun activation.
In the AD brains, which usually degenerate for more
than several years, it is possible that both c-jun–associated
and c-jun–nonassociated neuronal deaths occur in various
situations. Although apoptosis itself is a rather rapid pro-
cess in a single neuron, it occurs in numerous neurons of
the brain at random and so the mass degeneration of the
brain proceeds gradually. Therefore, we are speculating
that c-jun–mediated apoptosis influenced by PS1 might be
an additive factor to modify neuronal fate in the AD brain,
and could function in parallel with the amyloid deposition
promoted by PS mutations as well as the pathogenic mech-
anisms mediated by other binding proteins.
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